Q1. | Are you aware of the guidance from AASLD and EASL with regards to HCC surveillance? |
Q2. | Do you carry out liver USS for HCC in your hospital? |
Q3. | What best describes the type of hospital you work in? |
Q4. | How is HCC surveillance arranged in your hospital? |
Q5. | Does your programme ensure that patients have an ultrasound on a 6-monthly basis? |
Q6. | Do your patients get a written or verbal explanation as to why HCC surveillance is performed? |
Q7. | Are ultrasound examinations on patients with cirrhosis reviewed by a dedicated radiographer/radiologist with expertise in HCC surveillance? |
Q8. | What are the entry criteria for your HCC surveillance programme? (Select as many as you wish). |
Q9. | Do you offer HCC surveillance for patients with autoimmune liver diseases, that is, autoimmune hepatitis, primary biliary cirrhosis, primary sclerosing cholangitis? |
Q10. | On which criteria do you base a diagnosis of cirrhosis for the purpose of surveillance? (select as many as required) |
Q11. | Do you believe that HCC surveillance is cost-effective? |
Q12. | Do you believe that HCC surveillance improves patient outcomes? |
Q13. | What barriers are there preventing the implementation of 6-monthly USS? |
Q14. | What routinely happens to abnormal USS? |
Q15. | Are there groups who should not have HCC surveillance? |
Q16. | Does your hospital have a comprehensive liver database for all patients attending your hospital? |
Q17. | Do you have a regular audit programme to assess detection rates for HCC from your surveillance programme? |
Q18. | How many patients have been identified with HCC from your surveillance programme in the last 12 months? |
Q19. | How many patients have been identified with HCC outside of a surveillance programme in your hospital in the last 12 months? |
Q20. | Does your hospital have a dedicated hepatologist to see patients with cirrhosis? |
Q21. | How would you describe yourself? |
Q22. | In which part of Britain do you work? |
Q23. | Do you have a lead consultant for hepatology in your hospital? |
Q24. | How many consultants are involved in your hepatology service? |
AASLD, American Association for the Study of Liver Diseases; EASL, European Association for the Study of the Liver; HCC, hepatocellular carcinoma; USS, ultrasound surveillance.